e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novocure Ltd Ord Sh
(NQ:
NVCR
)
17.65
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novocure Ltd Ord Sh
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
NovoCure (NVCR) Q3 2024 Earnings Call Transcript
October 30, 2024
NVCR earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Novocure Appoints Christoph Brackmann as Chief Financial Officer
October 30, 2024
From
Novocure
Via
Business Wire
Novocure Reports Third Quarter 2024 Financial Results
October 30, 2024
From
Novocure
Via
Business Wire
Deep Dive Into NovoCure Stock: Analyst Perspectives (4 Ratings)
October 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 16, 2024
Via
Benzinga
Why NovoCure Stock Dived by 13% This Week
September 06, 2024
Investors found the announced changes to the company's C-suite unsettling.
Via
The Motley Fool
Beyond The Numbers: 4 Analysts Discuss NovoCure Stock
July 26, 2024
Via
Benzinga
US Stocks Could Open Narrowly Mixed After Tuesday's Chip Sell-Off, Bitcoin Heads To $68K, Oil Slips
October 16, 2024
U.S. stock futures point to a flattish start on Wednesday after the S&P 500 Index and the Dow Jones Industrial Average retreated from record highs in the previous session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
FDA Approves NovoCure's Portable Device Producing Tumor-Treating Electric Fields For Previously Treated Lung Cancer Patients
October 16, 2024
NovoCure's Optune Lua, a tumor-treating fields device, gains FDA approval for use with PD-1/PD-L1 inhibitors or docetaxel in metastatic non-small cell lung cancer patients, demonstrating significant...
Via
Benzinga
Exposures
Product Safety
Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment
October 15, 2024
The company could have a long path ahead to reimbursement and, ultimately, sales.
Via
Investor's Business Daily
Exposures
Product Safety
FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer
October 15, 2024
From
Novocure
Via
Business Wire
Breaking Down NovoCure: 4 Analysts Share Their Views
July 02, 2024
Via
Benzinga
A Closer Look at 7 Analyst Recommendations For NovoCure
June 04, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 07, 2024
Via
Benzinga
Novocure to Report Third Quarter 2024 Financial Results
October 01, 2024
From
Novocure
Via
Business Wire
Novocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy
September 09, 2024
From
Novocure
Via
Business Wire
Novocure Announces Planned CEO Transition
September 03, 2024
From
Novocure
Via
Business Wire
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 03, 2024
Via
Benzinga
Novocure to Participate in 2024 Wells Fargo Healthcare Conference
August 28, 2024
From
Novocure
Via
Business Wire
Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer
August 14, 2024
From
Novocure
Via
Business Wire
Chips, Glorious Chips!
August 07, 2024
Someone's gotta make 'em, and someone's gotta buy 'em.
Via
The Motley Fool
PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday
July 30, 2024
Via
Benzinga
NovoCure (NVCR) Q2 2024 Earnings Call Transcript
July 25, 2024
NVCR earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
NVCR Stock Earnings: NovoCure Beats EPS, Beats Revenue for Q2 2024
July 25, 2024
NVCR stock results show that NovoCure beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Novocure Reports Second Quarter 2024 Financial Results
July 25, 2024
From
Novocure
Via
Business Wire
Novocure to Report Second Quarter 2024 Financial Results
July 01, 2024
From
Novocure
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
June 07, 2024
Via
Benzinga
METIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free Survival
June 03, 2024
From
Novocure
Via
Business Wire
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
May 20, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 15, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
wpDiscuz
Insert
